心不全POCおよびLOCデバイスの市場規模、シェア、動向分析レポート：検査タイプ別、技術別、最終用途別、地域別、およびセグメント予測：2023～2030年

心不全POCおよびLOCデバイス市場の成長と動向：

Grand View Research, Inc.の最新レポートによると、世界の心不全POCおよびLOCデバイス市場規模は2030年までに2億8,490万米ドルに達し、2023年から2030年までのCAGRは16.9％で成長すると予測されています。

診断分野のパラダイムシフトが、ヘルスケアコストの上昇を抑制するための実行可能な戦略として、後期段階の疾患検出から疾患の早期特定へとシフトしていることが、市場を牽引しています。このシフトは、心臓発作を起こすリスクを評価するために1つの検体から心臓バイオマーカーを検出するために、様々なセンサと関連アクセサリを1つの空間に統合した使い捨てで低コストのLOCデバイスの開発につながっています。

さらに、LOCアッセイによって測定されたデータを分析して治療モニタリングを可能にする予測モデリング技術ベースの意思決定支援ソフトウェアの開発は、市場促進要因の1つです。また、心筋梗塞を測定するための唾液ベースのナノ・バイオチップ検査の応用に関する進行中の研究が、有機的な収益成長の原動力となっています。

POC検査は、病院、一般診療所、遠隔地など、さまざまな環境において節約の可能性を示しています。米国では、POC機器の採用により胸痛治療室への入院が20％減少し、時間とコストの大幅な節約につながっています。

心臓観察室（米国）では、POCトロポニン検査の導入により、在院日数が短縮され、入院率が低下し、費用のかかる複数の処置の必要性がなくなり、患者1人当たり25％のコスト削減が実現しました。さらに、個人の心臓の健康を管理するためのPOC診断におけるスマートフォンとアプリの統合は、心不全POCおよびLOCデバイス市場における重要な技術革新の1つです。

心不全POCおよびLOCデバイス市場レポートハイライト

• プロテオミクス分析には、トロポニン、ミオグロビン、クレアチンキナーゼMBアイソザイム（CK-MB）などのタンパク質マーカーを検査する製品が含まれます。
• 現在入手可能な製品のほとんどがタンパク質マーカーの検査に基づいているため、このセグメントは主要な収益シェアを占めています。
• 推定バイオマーカーを評価するためのマイクロ流体LOC技術の導入が増加していることが、この技術の最大の収益シェアにつながっています。
• マイクロ流体技術は、免疫ハイブリダイゼーション技術、酵素アッセイ、PCRなど、さまざまな生物学的アプリケーションに導入されています。
• 医院、薬局・小売クリニック、急患診療所、非診療所を含む診療所は、主要な収益を生み出すエンドユーザーです。
• 一般開業医によるPOC機器の高い使用率は、迅速な調査、早期治療の決定、タイムリーな紹介、患者の不確実性の軽減のためであり、診療所を通じた収益成長の原動力となっています。
• 米国は、心不全の早期発見の手段としてPOC心臓マーカー検査を導入しているプライマリケアクリニックの数が多いため、世界の心不全POC＆LOCデバイス市場を独占しています。
• 都市化の拡大と老年人口の増加が、アジア諸国における日常的な心臓健康モニタリングのためのPOC診断のような強固で改善されたヘルスケアサービスへの需要を下支えしています。
• さらに、POC心筋トロポニンT/心筋トロポニンIバイオマーカーに関する若いヘルスケア担当者のトレーニングに向けた取り組みも行われています。
• この結果、アジア諸国ではPOC機器の採用率が急上昇すると予想されます。
• Abbott社、Siemens Healthineers社、Danahar社、F. Hoffmann-La Roche社などがこの分野で事業を展開している主要企業です。
• 各社は新興企業のM&Aに取り組んでいます。AbbottによるAlereの買収、DanaharによるBeckman Coulter, Incの買収、Instrumentation LaboratoryによるAccriva Diagnosticsの買収は、この市場における買収の一例です。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 心不全POCおよびLOCデバイスの市場変数、動向および範囲

• 市場系統の見通し
  • 親市場の見通し
  • 関連/付随市場の見通し
• 普及と成長の見通しマッピング
• 市場力学
  • 市場促進要因の分析
  • 市場抑制要因分析
• 心不全POCおよびLOCデバイス市場分析ツール
  • 業界分析- ポーターのファイブフォース分析
  • PESTEL分析

第4章 心不全POCおよびLOCデバイス：検査タイプ別推定・動向分析

• 心不全POCおよびLOCデバイス市場：重要なポイント
• 心不全POCおよびLOCデバイス市場：動向および市場シェア分析、2022年および2030年
• プロテオミクス検査
• メタボローム検査
• ゲノム検査

第5章 心不全POCおよびLOCデバイス：技術別推定・動向分析

• 心不全POCおよびLOCデバイス市場：重要なポイント
• 心不全POCおよびLOCデバイス市場：動向および市場シェア分析、2022年および2030年
• マイクロ流体工学
• アレイベースのシステム
• その他

第6章 心不全POCおよびLOCデバイス：最終用途別推定・動向分析

• 心不全POCおよびLOCデバイス市場：重要なポイント
• 心不全POCおよびLOCデバイス市場：動向および市場シェア分析、2022年および2030年
• クリニック
• 病院
• ホーム
• 介護付きヘルスケア施設
• ラボ

第7章 心不全POCおよびLOCデバイス市場：地域別推定・動向分析

• 地域別の展望
• 地域別の心不全POCおよびLOCデバイス市場：重要なポイント
• 北米
• 欧州
• アジア太平洋地域
• ラテンアメリカ
• 中東・アフリカ

第8章 競合情勢

• 主要市場参入企業による最近の動向と影響分析
• 市場参入企業の分類
  • Abbott Laboratories
  • Siemens Healthineers
  • Danaher
  • Instrumentation Laboratory
  • F. Hoffmann-La Roche Ltd.
  • bioMerieux S.A.
  • Abaxis, Inc.
  • Quidel Corporation
  • Jant Pharmacal Corporation
  • Trinity Biotech

List of Tables

• Table 1 List of Abbreviation
• Table 2 North America heart failure POC & LOC devices market, by test type, 2018 - 2030 (USD Million)
• Table 3 North America heart failure POC & LOC devices market, by technology, 2018 - 2030 (USD Million)
• Table 4 North America heart failure POC & LOC devices market, by end use, 2018 - 2030 (USD Million)
• Table 5 North America heart failure POC & LOC devices market, by region, 2018 - 2030 (USD Million)
• Table 6 U.S. heart failure POC & LOC devices market, by test type, 2018 - 2030 (USD Million)
• Table 7 U.S. heart failure POC & LOC devices market, by technology, 2018 - 2030 (USD Million)
• Table 8 U.S. heart failure POC & LOC devices market, by end use, 2018 - 2030 (USD Million)
• Table 9 Canada heart failure POC & LOC devices market, by test type, 2018 - 2030 (USD Million)
• Table 10 Canada heart failure POC & LOC devices market, by technology, 2018 - 2030 (USD Million)
• Table 11 Canada heart failure POC & LOC devices market, by end use, 2018 - 2030 (USD Million)
• Table 12 Europe heart failure POC & LOC devices market, by test type, 2018 - 2030 (USD Million)
• Table 13 Europe heart failure POC & LOC devices market, by technology, 2018 - 2030 (USD Million)
• Table 14 Europe heart failure POC & LOC devices market, by end use, 2018 - 2030 (USD Million)
• Table 15 Europe heart failure POC & LOC devices market, by region, 2018 - 2030 (USD Million)
• Table 16 Germany heart failure POC & LOC devices market, by test type, 2018 - 2030 (USD Million)
• Table 17 Germany heart failure POC & LOC devices market, by technology, 2018 - 2030 (USD Million)
• Table 18 Germany heart failure POC & LOC devices market, by end use, 2018 - 2030 (USD Million)
• Table 19 UK heart failure POC & LOC devices market, by test type, 2018 - 2030 (USD Million)
• Table 20 UK heart failure POC & LOC devices market, by technology, 2018 - 2030 (USD Million)
• Table 21 UK heart failure POC & LOC devices market, by end use, 2018 - 2030 (USD Million)
• Table 22 France heart failure POC & LOC devices market, by test type, 2018 - 2030 (USD Million)
• Table 23 France heart failure POC & LOC devices market, by technology, 2018 - 2030 (USD Million)
• Table 24 France heart failure POC & LOC devices market, by end use, 2018 - 2030 (USD Million)
• Table 25 Italy heart failure POC & LOC devices market, by test type, 2018 - 2030 (USD Million)
• Table 26 Italy heart failure POC & LOC devices market, by technology, 2018 - 2030 (USD Million)
• Table 27 Italy heart failure POC & LOC devices market, by end use, 2018 - 2030 (USD Million)
• Table 28 Spain heart failure POC & LOC devices market, by test type, 2018 - 2030 (USD Million)
• Table 29 Spain heart failure POC & LOC devices market, by technology, 2018 - 2030 (USD Million)
• Table 30 Spain heart failure POC & LOC devices market, by end use, 2018 - 2030 (USD Million)
• Table 31 Denmark heart failure POC & LOC devices market, by test type, 2018 - 2030 (USD Million)
• Table 32 Denmark heart failure POC & LOC devices market, by technology, 2018 - 2030 (USD Million)
• Table 33 Denmark heart failure POC & LOC devices market, by end use, 2018 - 2030 (USD Million)
• Table 34 Sweden heart failure POC & LOC devices market, by test type, 2018 - 2030 (USD Million)
• Table 35 Sweden heart failure POC & LOC devices market, by technology, 2018 - 2030 (USD Million)
• Table 36 Sweden heart failure POC & LOC devices market, by end use, 2018 - 2030 (USD Million)
• Table 37 Norway heart failure POC & LOC devices market, by test type, 2018 - 2030 (USD Million)
• Table 38 Norway heart failure POC & LOC devices market, by technology, 2018 - 2030 (USD Million)
• Table 39 Norway heart failure POC & LOC devices market, by end use, 2018 - 2030 (USD Million)
• Table 40 Asia Pacific heart failure POC & LOC devices market, by test type, 2018 - 2030 (USD Million)
• Table 41 Asia Pacific heart failure POC & LOC devices market, by technology, 2018 - 2030 (USD Million)
• Table 42 Asia Pacific heart failure POC & LOC devices market, by end use, 2018 - 2030 (USD Million)
• Table 43 Asia Pacific heart failure POC & LOC devices market, by region, 2018 - 2030 (USD Million)
• Table 44 Japan heart failure POC & LOC devices market, by test type, 2018 - 2030 (USD Million)
• Table 45 Japan heart failure POC & LOC devices market, by technology, 2018 - 2030 (USD Million)
• Table 46 Japan heart failure POC & LOC devices market, by end use, 2018 - 2030 (USD Million)
• Table 47 China heart failure POC & LOC devices market, by test type, 2018 - 2030 (USD Million)
• Table 48 China heart failure POC & LOC devices market, by technology, 2018 - 2030 (USD Million)
• Table 49 China heart failure POC & LOC devices market, by end use, 2018 - 2030 (USD Million)
• Table 50 India heart failure POC & LOC devices market, by test type, 2018 - 2030 (USD Million)
• Table 51 India heart failure POC & LOC devices market, by technology, 2018 - 2030 (USD Million)
• Table 52 India heart failure POC & LOC devices market, by end use, 2018 - 2030 (USD Million)
• Table 53 Australia heart failure POC & LOC devices market, by test type, 2018 - 2030 (USD Million)
• Table 54 Australia heart failure POC & LOC devices market, by technology, 2018 - 2030 (USD Million)
• Table 55 Australia heart failure POC & LOC devices market, by end use, 2018 - 2030 (USD Million)
• Table 56 Thailand heart failure POC & LOC devices market, by test type, 2018 - 2030 (USD Million)
• Table 57 Thailand heart failure POC & LOC devices market, by technology, 2018 - 2030 (USD Million)
• Table 58 Thailand heart failure POC & LOC devices market, by end use, 2018 - 2030 (USD Million)
• Table 59 South Korea heart failure POC & LOC devices market, by test type, 2018 - 2030 (USD Million)
• Table 60 South Korea heart failure POC & LOC devices market, by technology, 2018 - 2030 (USD Million)
• Table 61 South Korea heart failure POC & LOC devices market, by end use, 2018 - 2030 (USD Million)
• Table 62 Latin America heart failure POC & LOC devices market, by test type, 2018 - 2030 (USD Million)
• Table 63 Latin America heart failure POC & LOC devices market, by technology, 2018 - 2030 (USD Million)
• Table 64 Latin America heart failure POC & LOC devices market, by end use, 2018 - 2030 (USD Million)
• Table 65 Latin America heart failure POC & LOC devices market, by region, 2018 - 2030 (USD Million)
• Table 66 Brazil heart failure POC & LOC devices market, by test type, 2018 - 2030 (USD Million)
• Table 67 Brazil heart failure POC & LOC devices market, by technology, 2018 - 2030 (USD Million)
• Table 68 Brazil heart failure POC & LOC devices market, by end use, 2018 - 2030 (USD Million)
• Table 69 Mexico heart failure POC & LOC devices market, by test type, 2018 - 2030 (USD Million)
• Table 70 Mexico heart failure POC & LOC devices market, by technology, 2018 - 2030 (USD Million)
• Table 71 Mexico heart failure POC & LOC devices market, by end use, 2018 - 2030 (USD Million)
• Table 72 Argentina heart failure POC & LOC devices market, by test type, 2018 - 2030 (USD Million)
• Table 73 Argentina heart failure POC & LOC devices market, by technology, 2018 - 2030 (USD Million)
• Table 74 Argentina heart failure POC & LOC devices market, by end use, 2018 - 2030 (USD Million)
• Table 75 Middle East and Africa heart failure POC & LOC devices market, by test type, 2018 - 2030 (USD Million)
• Table 76 Middle East and Africa heart failure POC & LOC devices market, by technology, 2018 - 2030 (USD Million)
• Table 77 Middle East and Africa heart failure POC & LOC devices market, by end use, 2018 - 2030 (USD Million)
• Table 78 Middle East and Africa heart failure POC & LOC devices market, by region, 2018 - 2030 (USD Million)
• Table 79 South Africa heart failure POC & LOC devices market, by test type, 2018 - 2030 (USD Million)
• Table 80 South Africa heart failure POC & LOC devices market, by technology, 2018 - 2030 (USD Million)
• Table 81 South Africa heart failure POC & LOC devices market, by end use, 2018 - 2030 (USD Million)
• Table 82 Saudi Arabia heart failure POC & LOC devices market, by test type, 2018 - 2030 (USD Million)
• Table 83 Saudi Arabia heart failure POC & LOC devices market, by technology, 2018 - 2030 (USD Million)
• Table 84 Saudi Arabia heart failure POC & LOC devices market, by end use, 2018 - 2030 (USD Million)
• Table 85 UAE heart failure POC & LOC devices market, by test type, 2018 - 2030 (USD Million)
• Table 86 UAE heart failure POC & LOC devices market, by technology, 2018 - 2030 (USD Million)
• Table 87 UAE heart failure POC & LOC devices market, by end use, 2018 - 2030 (USD Million)
• Table 88 Kuwait heart failure POC & LOC devices market, by test type, 2018 - 2030 (USD Million)
• Table 89 Kuwait heart failure POC & LOC devices market, by technology, 2018 - 2030 (USD Million)
• Table 90 Kuwait heart failure POC & LOC devices market, by end use, 2018 - 2030 (USD Million)

List of Figures

• Fig. 1 Market research process
• Fig. 2 Data triangulation techniques
• Fig. 3 Primary research pattern
• Fig. 4 Market research approaches
• Fig. 5 Value-chain-based sizing & forecasting
• Fig. 6 QFD modeling for market share assessment
• Fig. 7 Market formulation & validation
• Fig. 8 Heart failure POC & LOC devices: Market outlook
• Fig. 9 Heart failure POC & LOC devices: Competitive insights
• Fig. 10 Parent market outlook
• Fig. 11 Related/ancillary market outlook
• Fig. 12 Penetration and growth prospect mapping
• Fig. 13 Industry value chain analysis
• Fig. 14 Heart failure POC & LOC devices market driver impact
• Fig. 15 Heart failure POC & LOC devices market restraint impact
• Fig. 16 Heart failure POC & LOC devices market strategic initiatives analysis
• Fig. 17 Heart failure POC & LOC devices market: Test type movement analysis
• Fig. 18 Heart failure POC & LOC devices market: Test type outlook and key takeaways
• Fig. 19 Solid market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 20 Proteomic testing market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 21 Metabolomic testing market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 22 Genomic testing market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 23 Heart failure POC & LOC devices market: Technology movement analysis
• Fig. 24 Heart failure POC & LOC devices market: Technology outlook and key takeaways
• Fig. 25 Microfluidics market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 26 Array-based systems market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 27 Others market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 28 Heart failure POC & LOC devices market: End use movement analysis
• Fig. 29 Heart failure POC & LOC devices market: End use outlook and key takeaways
• Fig. 30 Clinics market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 31 Hospitals market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 32 Home market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 33 Assisted living healthcare facilities market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 34 Laboratory market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 35 Global heart failure POC & LOC devices market: Regional movement analysis
• Fig. 36 Global heart failure POC & LOC devices market: Regional outlook and key takeaways
• Fig. 37 North America market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 38 U.S. market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 39 Canada market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 40 Europe. market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 41 UK market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 42 Germany market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 43 France market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 44 Italy market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 45 Spain market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 46 Denmark market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 47 Sweden market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 48 Norway market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 49 Asia Pacific market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 50 Japan market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 51 China market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 52 India market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 53 Australia market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 54 Thailand market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 55 South Korea market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 56 Latin America market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 57 Brazil market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 58 Mexico market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 59 Argentina market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 60 Middle East and Africa. market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 61 South Africa market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 62 Saudi Arabia market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 63 UAE market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 64 Kuwait market estimates and forecasts, 2018 - 2030 (USD Million)

Heart Failure POC And LOC Devices Market Growth & Trends:

The global heart failure POC and LOC devices market size is expected to reach USD 284.9 million by 2030 and is projected to grow at a CAGR of 16.9% from 2023 to 2030, according to a new report by Grand View Research, Inc.. A paradigm shift in diagnostic sectors from late-stage disease detection to early identification of diseases as a viable strategy to curb rising healthcare costs has driven the market. This shift has led to the development of disposable and low-cost LOC devices that integrate various sensors and associated accessories in a single space for detection of the cardiac biomarkers from a single specimen to evaluate the risk of having a heart attack.

Furthermore, the development of predictive modeling techniques-based decision support software to analyze the data measured by the LOC assays to enable therapy monitoring is one of the key market drivers. Also, ongoing studies on the application of saliva-based nano-biochip tests for measuring myocardial infarction is driving organic revenue growth.

POC testing exhibits potential savings across various settings, including hospitals, general practice, and remote areas. In the U.S., the employment of POC devices resulted in a 20% decrease in hospital admissions to the chest pain unit, resulting in substantial savings in time and costs.

In the cardiac observation unit (U.S.), the implementation of POC troponin testing helped reduce hospital stays, decrease admission rates, and remove the need for multiple costly procedures, resulting in 25% cost saving per patient. Furthermore, the integration of smartphones and apps in POC diagnostics for managing the cardiac health of an individual is one of the significant innovations in Heart Failure POC & LOC Devices market.

Heart Failure POC And LOC Devices Market Report Highlights:

• Proteomic analysis includes products that test protein markers, such as troponin, myoglobin, and Creatine Kinase MB Isoenzyme (CK-MB)
• This segment accounted for the leading revenue share, as most of the currently available products are based on testing of protein markers
• Increasing implementation of microfluidic LOC technology for assessing putative biomarkers has led to the largest revenue share of this technology
• Microfluidic technologyhas been implemented for various biological applications, such as immunohybridization techniques, enzymatic assays, PCR, and others
• Clinics that include physician's office, pharmacy & retail clinics, urgent care clinics, and non-practice clinics are the key revenue generating end-users
• A high usage rate of POC devices by general practitioners for rapid investigation, deciding early treatment, timely referral, and less uncertainty for patients has driven the revenue growth through clinics
• The U.S. dominated the global Heart Failure POC & LOC devices market owing to the presence of a substantial number of primary care clinics that are deploying POC cardiac marker test as a measure for early detection of heart failure
• Expanding urbanization and increasing geriatric population underpin the demand for robust and improved healthcare services such as POC diagnostics for routine cardiac health monitoring in Asian countries
• Moreover, initiatives are undertaken for training young healthcare personnel about POC cardiac troponin T/cardiac troponin I biomarkers
• This, in turn, is anticipated to result in the surging adoption rate of POC devices in Asian countries
• Abbott, Siemens Healthineers, Danahar, and F. Hoffmann-La Roche Ltd are some key participants operating in the space
• Companies are engaged in mergers and acquisitions of emerging players. Acquisition of Alere by Abbott, Beckman Coulter, Inc by Danahar, and Accriva Diagnostics by Instrumentation Laboratory are some examples of acquisitions in this market

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
  • 1.1.1. Test type
  • 1.1.2. Technology
  • 1.1.3. End use
  • 1.1.4. Regional scope
  • 1.1.5. Estimates and forecast timeline
• 1.2. Research Methodology
• 1.3. Information Procurement
  • 1.3.1. Purchased database
  • 1.3.2. GVR's internal database
  • 1.3.3. Secondary sources
  • 1.3.4. Primary research
  • 1.3.5. Details of primary research
• 1.4. Information or Data Analysis
• 1.5. Market Formulation & Validation
• 1.6. Model Details
• 1.7. List of Secondary Sources
• 1.8. List of Primary Sources
• 1.9. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
  • 2.2.1. Test type outlook
  • 2.2.2. Technology outlook
  • 2.2.3. End use outlook
  • 2.2.4. Regional outlook
• 2.3. Competitive Insights

Chapter 3. Heart Failure POC & LOC Devices Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent market outlook
  • 3.1.2. Related/ancillary market outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Market Dynamics
  • 3.3.1. Market driver analysis
  • 3.3.2. Market restraint analysis
• 3.4. Heart Failure POC & LOC Devices Market Analysis Tools
  • 3.4.1. Industry Analysis - Porter's
    • 3.4.1.1. Supplier power
    • 3.4.1.2. Buyer power
    • 3.4.1.3. Substitution threat
    • 3.4.1.4. Threat of new entrant
    • 3.4.1.5. Competitive rivalry
  • 3.4.2. PESTEL Analysis
    • 3.4.2.1. Political landscape
    • 3.4.2.2. Technological landscape
    • 3.4.2.3. Economic landscape

Chapter 4. Heart Failure POC & LOC Devices: Test Type Estimates & Trend Analysis

• 4.1. Heart Failure POC & LOC Devices Market: Key Takeaways
• 4.2. Heart Failure POC & LOC Devices Market: Movement & Market Share Analysis, 2022 & 2030
• 4.3. Proteomic Testing
  • 4.3.1. Proteomic testing market estimates and forecasts, 2018 to 2030 (USD Million)
• 4.4. Metabolomic Testing
  • 4.4.1. Metabolomic testing market estimates and forecasts, 2018 to 2030 (USD Million)
• 4.5. Genomic Testing
  • 4.5.1. Genomic testing market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 5. Heart Failure POC & LOC Devices: Technology Estimates & Trend Analysis

• 5.1. Heart Failure POC & LOC Devices Market: Key Takeaways
• 5.2. Heart Failure POC & LOC Devices Market: Movement & Market Share Analysis, 2022 & 2030
• 5.3. Microfluidics
  • 5.3.1. Microfluidics market estimates and forecasts, 2018 to 2030 (USD Million)
• 5.4. Array-based Systems
  • 5.4.1. Array-based systems market estimates and forecasts, 2018 to 2030 (USD Million)
• 5.5. Others
  • 5.5.1. Others market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 6. Heart Failure POC & LOC Devices: End Use Estimates & Trend Analysis

• 6.1. Heart Failure POC & LOC Devices Market: Key Takeaways
• 6.2. Heart Failure POC & LOC Devices Market: Movement & Market Share Analysis, 2022 & 2030
• 6.3. Clinics
  • 6.3.1. Clinics market estimates and forecasts, 2018 to 2030 (USD Million)
• 6.4. Hospitals
  • 6.4.1. Hospitals market estimates and forecasts, 2018 to 2030 (USD Million)
• 6.5. Home
  • 6.5.1. Home market estimates and forecasts, 2018 to 2030 (USD Million)
• 6.6. Assisted Living Healthcare Facilities
  • 6.6.1. Assisted living healthcare facilities market estimates and forecasts, 2018 to 2030 (USD Million)
• 6.7. Laboratory
  • 6.7.1. Laboratory market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 7. Heart Failure POC & LOC Devices Market: Regional Estimates & Trend Analysis

• 7.1. Regional Outlook
• 7.2. Heart Failure POC & LOC Devices Market by Region: Key Takeaways
• 7.3. North America
  • 7.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 7.3.2. U.S.
    • 7.3.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 7.3.3. Canada
    • 7.3.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
• 7.4. Europe
  • 7.4.1. UK
    • 7.4.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 7.4.2. Germany
    • 7.4.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 7.4.3. France
    • 7.4.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 7.4.4. Italy
    • 7.4.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 7.4.5. Spain
    • 7.4.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 7.4.6. Denmark
    • 7.4.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 7.4.7. Sweden
    • 7.4.7.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 7.4.8. Norway
    • 7.4.8.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
• 7.5. Asia Pacific
  • 7.5.1. Japan
    • 7.5.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 7.5.2. China
    • 7.5.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 7.5.3. India
    • 7.5.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 7.5.4. Australia
    • 7.5.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 7.5.5. Thailand
    • 7.5.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 7.5.6. South Korea
    • 7.5.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
• 7.6. Latin America
  • 7.6.1. Brazil
    • 7.6.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 7.6.2. Mexico
    • 7.6.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 7.6.3. Argentina
    • 7.6.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
• 7.7. MEA
  • 7.7.1. South Africa
    • 7.7.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 7.7.2. Saudi Arabia
    • 7.7.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 7.7.3. UAE
    • 7.7.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 7.7.4. Kuwait
    • 7.7.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)

Chapter 8. Competitive Landscape

• 8.1. Recent Developments & Impact Analysis, By Key Market Participants
• 8.2. Market Participant Categorization
  • 8.2.1. Abbott Laboratories
    • 8.2.1.1. Company overview
    • 8.2.1.2. Financial performance
    • 8.2.1.3. Product benchmarking
    • 8.2.1.4. Strategic initiatives
  • 8.2.2. Siemens Healthineers
    • 8.2.2.1. Company overview
    • 8.2.2.2. Financial performance
    • 8.2.2.3. Product benchmarking
    • 8.2.2.4. Strategic initiatives
  • 8.2.3. Danaher
    • 8.2.3.1. Company overview
    • 8.2.3.2. Financial performance
    • 8.2.3.3. Product benchmarking
    • 8.2.3.4. Strategic initiatives
  • 8.2.4. Instrumentation Laboratory
    • 8.2.4.1. Company overview
    • 8.2.4.2. Financial performance
    • 8.2.4.3. Product benchmarking
    • 8.2.4.4. Strategic initiatives
  • 8.2.5. F. Hoffmann-La Roche Ltd.
    • 8.2.5.1. Company overview
    • 8.2.5.2. Financial performance
    • 8.2.5.3. Product benchmarking
    • 8.2.5.4. Strategic initiatives
  • 8.2.6. bioMerieux S.A.
    • 8.2.6.1. Company overview
    • 8.2.6.2. Financial performance
    • 8.2.6.3. Product benchmarking
    • 8.2.6.4. Strategic initiatives
  • 8.2.7. Abaxis, Inc.
    • 8.2.7.1. Company overview
    • 8.2.7.2. Financial performance
    • 8.2.7.3. Product benchmarking
    • 8.2.7.4. Strategic initiatives
  • 8.2.8. Quidel Corporation
    • 8.2.8.1. Company overview
    • 8.2.8.2. Financial performance
    • 8.2.8.3. Product benchmarking
    • 8.2.8.4. Strategic initiatives
  • 8.2.9. Jant Pharmacal Corporation
    • 8.2.9.1. Company overview
    • 8.2.9.2. Financial performance
    • 8.2.9.3. Product benchmarking
    • 8.2.9.4. Strategic initiative
  • 8.2.10. Trinity Biotech
    • 8.2.10.1. Company overview
    • 8.2.10.2. Financial performance
    • 8.2.10.3. Product benchmarking
    • 8.2.10.4. Strategic initiatives